is tirzepatide a weekly injection π₯ once-weekly that is a first-in-class medicine that activates the GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors. These hormones regulate blood sugar levels, suppress Tirzepatide (Mounjaro): Type 2 Diabetes
Description
Published on The Food and Drug Administration (FDA) has approved semaglutide tablets as the first oral GLP-1 medicine for obesity in adults

Injection Technique and Timing Both Retatrutide and Mounjaro are administered via once-weekly subcutaneous injection

Hair loss could also be due to genetics, vitamin deficiency, stress, or other health conditions

Compounded drugs are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness, or quality before marketing

Animal studies demonstrate that GLP-1 receptor agonists reduce dopamine signaling in this pathway

GLP-1 slows stomach emptying and appetite
